SCI Pharmtech, Inc. (TPE:4119)

SCI Pharmtech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	386.93	582.38	942.06	166.83	332.23	633.03
Trading Asset Securities	124.5	110.37	89	97.55	360.4	-
Cash & Short-Term Investments	511.43	692.76	1,031	264.37	692.63	633.03
Cash Growth	-48.57%	-32.81%	290.00%	-61.83%	9.42%	-37.91%
Accounts Receivable	240.29	289.51	307.37	173.57	82.98	337.75
Other Receivables	0.16	-	0.15	31.1	265.59	519.65
Receivables	240.45	289.51	307.52	204.67	348.56	857.4
Inventory	600.54	620.9	529.53	513.43	294.18	380.88
Other Current Assets	63.03	57.22	85.13	59.93	61.93	47.5
Total Current Assets	1,415	1,660	1,953	1,042	1,397	1,919
Property, Plant & Equipment	4,955	4,803	3,912	3,194	2,100	1,503
Long-Term Investments	265.64	237.52	241.62	208.04	124.97	753.65
Other Intangible Assets	35.69	37.77	46.15	54.58	60.29	41.32
Long-Term Deferred Tax Assets	143.82	143.82	153.28	167.25	241.55	263.55
Other Long-Term Assets	265.64	318.06	384.69	294.11	265.64	89.89
Total Assets	7,081	7,201	6,691	4,961	4,190	4,570
Accounts Payable	51.2	58.44	44.25	48.64	33.78	80.88
Accrued Expenses	-	116.05	110.72	128.35	121.46	204.76
Short-Term Debt	0.1	0.1	175	112	-	-
Current Portion of Long-Term Debt	-	403.44	20	-	-	-
Current Portion of Leases	2.35	2.47	1.95	0.83	1.58	1.34
Current Income Taxes Payable	92.8	85.25	11.54	3.86	-	127.49
Current Unearned Revenue	61.7	94.92	38.37	31.77	41.76	97.3
Other Current Liabilities	715.08	253.72	168.07	444.86	549.35	610.45
Total Current Liabilities	923.23	1,014	569.89	770.32	747.94	1,122
Long-Term Debt	490.68	578.01	842.67	432.36	-	-
Long-Term Leases	5.81	6.37	2.86	0.2	0.57	1.25
Long-Term Unearned Revenue	-	-	-	4.11	-	-
Long-Term Deferred Tax Liabilities	104.45	104.45	146	103.81	103.81	103.81
Other Long-Term Liabilities	20.47	8.68	7.84	1	-	-
Total Liabilities	1,545	1,724	1,591	1,331	869.26	1,248
Common Stock	1,195	1,195	1,195	953.82	953.82	794.85
Additional Paid-In Capital	2,235	2,235	2,234	1,357	1,348	1,348
Retained Earnings	2,069	2,037	1,646	1,373	1,067	1,208
Comprehensive Income & Other	38.24	10.07	25.46	-54.73	-48.93	-29.38
Shareholders' Equity	5,537	5,477	5,100	3,629	3,321	3,322
Total Liabilities & Equity	7,081	7,201	6,691	4,961	4,190	4,570
Total Debt	498.94	990.39	1,042	545.38	2.16	2.59
Net Cash (Debt)	12.49	-297.63	-11.42	-281.01	690.48	630.44
Net Cash Growth	-	-	-	-	9.52%	-37.98%
Net Cash Per Share	0.10	-2.48	-0.10	-2.61	6.42	5.84
Filing Date Shares Outstanding	117.54	119.51	119.51	107.3	107.3	107.3
Total Common Shares Outstanding	117.54	119.51	119.51	107.3	107.3	107.3
Working Capital	492.22	646.01	1,383	272.08	649.37	796.6
Book Value Per Share	47.11	45.83	42.67	33.82	30.95	30.96
Tangible Book Value	5,501	5,439	5,054	3,575	3,260	3,281
Tangible Book Value Per Share	46.80	45.51	42.29	33.31	30.38	30.58
Land	-	687.88	687.88	687.88	825.68	825.68
Buildings	-	722.9	707	700.23	684.47	553.52
Machinery	-	2,467	1,786	1,185	577.08	576.8
Construction In Progress	-	1,965	1,565	1,323	633.3	222.71

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.